Scientific notes of P. F. Lesgaft University Scientific notes of P. F. Lesgaft University Ученые записки университета имени П.Ф. Лесгафта 1994-4683 2308-1961 111617 TYOLUU Педагогическая психология, психодиагностика цифровых образовательных сред Educational psychology, psychodiagnostics of digital educational environments Педагогическая психология, психодиагностика цифровых образовательных сред Global research trends in the field of Attention Deficit Hyperactivity Disorder biomarkers from 2013 to 2023: A bibliometric study Глобальные исследовательские тенденции в области биомаркеров синдрома дефицита внимания и гиперактивности с 2013 по 2023 год: библиометрическое исследование https://orcid.org/0009-0005-3912-737X Хун Янь Hong Yan https://orcid.org/0000-0001-5326-717X Цзин Ю Jing Yu Шэньянский педагогический университет Шэньян, Китай Россия Shenyang Normal University Shenyang, China Russian Federation Национальный исследовательский Томский государственный университет National Research Tomsk State University 30 09 2024 30 09 2024 9 299 305 23 06 2024 19 07 2024 https://uchzapiski.lesgaft.spb.ru/en/nauka/article/111617/view

. Синдром дефицита внимания и гиперактивности (СДВГ) является длительным, хроническим нейроразвивающим нарушением с глобальной распространенностью примерно 6,6%. В статье представлено исследование по комплексному библиометрическому анализу изучения биомаркеров СДВГ с 2013 по 2023 годы. Анализ кластеризации ключевых слов показал, что основные исследования направлены на полиморфизмы MiRNA, метилирование ДНК (DNAm) и ось мозг-кишечник. Эти биомаркеры могут быть использованы для ранней диагностики ADHD, лечения и оценки его эффективности.

The article presents a study on a comprehensive bibliometric analysis of the study of ADHD biomarkers from 2013 to 2023. Keyword clustering analysis has shown that the main research focuses on miRNA polymorphisms, DNA methylation (DNAm) and the brain-gut axis. These biomarkers can be used for early diagnosis of ADHD, treatment and evaluation of its effectiveness.

 синдром дефицита внимания и гиперактивности биомаркеры Attention deficit hyperactivity disorder Biomarkers

Salari N. [et al.]. The global prevalence of ADHD in children and adolescents: a systematic review and meta-analysis // Italian Journal of Pediatrics. 2023. № 1 (49). P. 48. Salari N. [et al.] (2023), “The global prevalence of ADHD in children and adolescents: a systematic review and meta-analysis”, Italian Journal of Pediatrics, № 1 (49), p. 48. Zanus C. [et al.]. Sleep Spindle-Related EEG Connectivity in Children with Attention-Deficit/Hyperactivity Disorder: An Exploratory Study // Entropy. 2023. № 9 (25). P. 1244. Zanus C. [et al.] (2023), “Sleep Spindle-Related EEG Connectivity in Children with Attention-Deficit/Hyperactivity Disorder: An Exploratory Study”, Entropy, № 9 (25), p. 1244. Velo S. [et al.]. Long-Term Effects of Multimodal Treatment on Psychopathology and Health-Related Quality of Life of Children With Attention Deficit Hyperactivity Disorder // Frontiers in psychology. 2019. V. 10. Velo S. [et al.] (2019), “Long-Term Effects of Multimodal Treatment on Psychopathology and Health-Related Quality of Life of Children With Attention Deficit Hyperactivity Disorder”, Frontiers in psychology, V. 10. Cascone A. D. [et al.]. Brain tissue iron neurophysiology and its relationship with the cognitive effects of dopaminergic modulation in children with and without ADHD // Developmental Cognitive Neuroscience. 2023. (63). P. 101274. Cascone A. D. [et al.] (2023), “Brain tissue iron neurophysiology and its relationship with the cognitive effects of dopaminergic modulation in children with and without ADHD”, Developmental Cognitive Neuroscience, (63), p. 101274. Sayal K. [et al.]. ADHD in children and young people: prevalence, care pathways, and service provision // The Lancet Psychiatry. 2018. № 2 (5). P. 175–186. Sayal K. [et al.] (2018), “ADHD in children and young people: prevalence, care pathways, and service provision”, The Lancet Psychiatry, № 2 (5), pp. 175–186. Waschbusch D. A. [et al.]. Inhibitory Control, Conduct Problems, and Callous Unemotional Traits in Children with ADHD and Typically Developing Children // Developmental Neuropsychology. 2022. № 1 (47). P. 42–59. Waschbusch D. A. [et al.] (2022), “Inhibitory Control, Conduct Problems, and Callous Unemotional Traits in Children with ADHD and Typically Developing Children”, Developmental Neuropsychology, № 1 (47), pp. 42–59. Cao C. [et al.]. Modeling Functional Brain Networks with Multi-Head Attention-based Region-Enhancement for ADHD Classification // Proceedings of the 2023 ACM international conference on multimedia retrieval, ICMR 2023. 2023. P. 362–369. Cao C. [et al.] (2023), “Modeling Functional Brain Networks with Multi-Head Attention-based Region-Enhancement for ADHD Classification”, Proceedings of the 2023 ACM International conference on multimedia retrieval, ICMR 2023, pp. 362–369. Blanco B. [et al.]. Cortical responses to social stimuli in infants at elevated likelihood of ASD and/or ADHD: A prospective cross-condition fNIRS study // CORTEX. 2023. (169). P. 18–34. Blanco B. [et al.] (2023), “Cortical responses to social stimuli in infants at elevated likelihood of ASD and/or ADHD: A prospective cross-condition fNIRS study”, Cortex, (169), pp. 18–34. Albajara Sáenz A., Villemonteix T., Massat I. Structural and functional neuroimaging in attention‐deficit/hyperactivity disorder // Developmental Medicine & Child Neurology. 2019. № 4 (61). P. 399–405. Albajara Sáenz A., Villemonteix T., Massat I. (2019), “Structural and functional neuroimaging in attention‐deficit/hyperactivity disorder”, Developmental Medicine & Child Neurology, № 4 (61), pp. 399–405. Batschelett M. A. [et al.]. Biomarkers of tic severity in children with Tourette syndrome: Motor cortex inhibition measured with transcranial magnetic stimulation // Developmental medicine and child neurology. 2023. № 10 (65). P. 1321–1331. Batschelett M. A. [et al.] (2023), “Biomarkers of tic severity in children with Tourette syndrome: Motor cortex inhibition measured with transcranial magnetic stimulation”, Developmental medicine and child neurology, № 10 (65), pp. 1321–1331. Torghabeh F. A., Hosseini S. A., Modaresnia Y. Potential biomarker for early detection of ADHD using phase-based brain connectivity and graph theory // Physical and engineering sciences in medicine. 2023. Torghabeh F. A., Hosseini S. A., Modaresnia Y. (2023), “Potential biomarker for early detection of ADHD using phase-based brain connectivity and graph theory”, Physical and engineering sciences in medicine. Dypas L. B. [et al.]. Blood miRNA levels associated with ADHD traits in children across six European birth cohorts // BMC PSYCHIATRY. 2023. № 1 (23). P. 696. Dypas L. B. [et al.] (2023), “Blood miRNA levels associated with ADHD traits in children across six European birth cohorts”, BMC psychiatry, № 1 (23), p. 696. Xu X. [et al.]. Dexmedetomidine alleviates host ADHD-like behaviors by reshaping the gut microbiota and reducing gut-brain inflammation // Psychiatry research. 2023. V. 323. Xu X. [et al.] (2023), “Dexmedetomidine alleviates host ADHD-like behaviors by reshaping the gut microbiota and reducing gut-brain inflammation”, Psychiatry Research, V. 323. Natsheh J. Y. [et al.]. The effects of the dopamine D2/3 agonist quinpirole on incentive value and palatability-based choice in a rodent model of attention-deficit/hyperactivity disorder // Psychopharmacology. 2021. V. 238, № 11. P. 3143–3153. Natsheh J. Y. [et al.] (2021), “The effects of the dopamine D2/3 agonist quinpirole on incentive value and palatability-based choice in a rodent model of attention-deficit/hyperactivity disorder”, Psychopharmacology, V. 238, № 11, pp. 3143–3153. Carpentieri V. [et al.]. DAT1 5’-Un-Translated-Region Methylation Patterns as Bio-Markers of ADHD Psycho-Pathology: Contribution to Disease Prognosis and to Monitoring of a Successful Therapy // Biomedicines. 2023. № 9 (11). P. 2546. Carpentieri V. [et al.] (2023), “DAT1 5’-Un-Translated-Region Methylation Patterns as Bio-Markers of ADHD Psycho-Pathology: Contribution to Disease Prognosis and to Monitoring of a Successful Therapy”, Biomedicines, № 9 (11), p. 2546. Vanicek T. [et al.]. Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET // Human Brain Mapping. 2017. № 2 (38). P. 792–802. Vanicek T. [et al.] (2017), “Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET”, Human Brain Mapping, № 2 (38), pp. 792–802. Lee S.-Y. [et al.]. Gut Leakage Markers and Cognitive Functions in Patients with Attention-Deficit/Hyperactivity Disorder // Children-Basel. 2023. № 3 (10). P. 513. Lee S.-Y. [et al.] (2023), “Gut Leakage Markers and Cognitive Functions in Patients with Attention-Deficit/Hyperactivity Disorder”, Children-Basel, № 3 (10), p. 513. Takahashi N. [et al.]. Interaction of genetic liability for attention deficit hyperactivity disorder (ADHD) and perinatal inflammation contributes to ADHD symptoms in children // Brain, Behavior, & Immunity - Health. 2023. (30). P. 100630. Takahashi N. [et al.] (2023), “Interaction of genetic liability for attention deficit hyperactivity disorder (ADHD) and perinatal inflammation contributes to ADHD symptoms in children”, Brain, Behavior, & Immunity – Health, (30), p. 100630. Subramani B. [et al.]. The Association of Bisphenol A and Parabens Exposure and Oxidative Stress in Attention-Deficit/Hyperactivity Disorder in Children and Adolescents // Exposure and health. 2023. Subramani B. [et al.] (2023), “The Association of Bisphenol A and Parabens Exposure and Oxidative Stress in Attention-Deficit/Hyperactivity Disorder in Children and Adolescents”, Exposure and health. Bratton T. K. [et al.]. Clinical Laboratory Approaches for Diagnoses of Sleep-Disordered Breathing and ADHD-Like Behavior in Children // Journal of applied laboratory medicine. 2023. № 3 (8). P. 568–582. Bratton T. K. [et al.] (2023), “Clinical Laboratory Approaches for Diagnoses of Sleep-Disordered Breathing and ADHD-Like Behavior in Children”, Journal of applied laboratory medicine, № 3 (8), pp. 568–582.